Adjuvance Technologies Inc.

New Filing
CIK: 0001652786·Biotechnology·DELAWARE·Filed: Sep 22, 2015
Total Offering

$7,000,000

Amount Sold

$1,000,000

Investors

1

First Sale

Aug 6, 2015

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Jeffrey Gardner
Related Person
Christopher Frigon
Related Person
Tyler Martin
Related Person
Mary Gin
Related Person
Phil Livingston
Related Person
Govind Ragupathi
Related Person
Gregory Poland
Related Person
John Gallo
Related Person

Company

Adjuvance Technologies Inc.

16 WEST 22ND STREET, 6TH FLOOR

NEW YORK, NY, 10010

2128459809

SEC Filing

0001652786-15-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Adjuvance Technologies Inc. Form D Filing — $7,000,000 | FilingFlow